Press release
Interim report
January 1 – June 30, 2015
The second quarter in figures
- Total net sales amounted to TSEK 918 (258).
- The loss after tax amounted to TSEK 10,939 (11,552).
- The loss per share amounted to SEK 1.80 (2.32).
- The cash flow from current operations was negative in the amount of TSEK 13,858 (7,959).
The half-year in figures
- Total net sales amounted to TSEK 1,975 (322).
- The loss after tax amounted to TSEK 20,118 (20,564).
- The loss per share amounted to SEK 3.63 (4.13).
- The cash flow from current operations was negative in the amount of TSEK 23,055(18,209).
Important events during the quarter
- In April, SciBase announced its intention to launch an Initial Public Offering and listing on Nasdaq First North.
- At an Extraordinary General Meeting on April 28, resolutions were taken to:
- introduce a share-based incentive program,
- consolidate shares and reduce the share capital,
- authorize the Board to make decisions regarding new share issues
- The Company completed a rights issue that raised MSEK 165 before issue costs. The Offering was significantly oversubscribed, resulting in a substantially broadened shareholder base consisting of both institutions and private shareholders. .
- The Company’s shares were listed on Nasdaq First North on June 2nd.
- Vinnova granted MSEK 3.9 for the development of the next generation device to SciBase and KTH.
- In April, an exclusive distributor agreement for the Austrian market was signed with Intramed Handels GesmbH.
- The Company expanded its sales resources in Germany.
- In April, SciBase established a Scientific Advisory Board consisting of international experts in the field of skin cancer
- The Company received an additional US patent approval.
Important events after the end of the period
- The Company announced that Pareto Securities has exercised the possibility to, in connection with the initial public offering of SciBase Holding AB (publ) (“SciBase”), carry out stabilization-like transactions.
Financial overview
| July 1 2014 - | ||||||||
| Apr 1 - Jun 30 | Jan 1 - Jun 30 | Jun 30 2015 | Jan 1 - Dec 31 | |||||
| THE GROUP | 2015 | 2014 | 2015 | 2014 | Rolling-12 | 2014 | ||
| Net sales, SEK ths | 918 | 258 | 1 975 | 322 | 3 253 | 1 600 | ||
| Gross margin, % | -34,5% | -10,1% | -14,6% | -11,2% | -25,5% | -36,0% | ||
| Equity/Asset ratio, % | 91,4% | 84,8% | 91,4% | 84,8% | 91,4% | 78,5% | ||
| Net indebtness, multiple | 0,09 | 0,18 | 0,09 | 0,18 | 0,09 | 0,27 | ||
| Cash equivalents, SEK ths | 165 595 | 46 903 | 165 595 | 46 903 | 165 595 | 27 566 | ||
| Cashflow from operating activities, SEK ths | -13 858 | -7 959 | -23 055 | -18 209 | -41 923 | -37 077 | ||
| Earnings per share (before and after dilution), SEK* | -1,80 | -2,32 | -3,63 | -4,13 | -7,26 | -7,78 | ||
| Shaeholder's equity per share, SEK* | 27,41 | 10,20 | 30,13 | 10,20 | 31,71 | 6,55 | ||
| Average number of shares, 000'* | 6 085 | 4 985 | 5 535 | 4 983 | 5 260 | 4 984 | ||
| Number of shares at closing of period, 000'* | 8 285 | 4 985 | 8 285 | 4 985 | 8 285 | 4 985 | ||
| Average number of employees | 13 | 11 | 14 | 11 | 13 | 12 | ||
| *Adjusted for in May 2015 performed reversed split, 40:1 | ||||||||